Poland’s Kamil Majchrzak stated he had failed a drug check, including that he didn’t knowingly take a banned substance and that the news got here as “the biggest shock.”
The 77th-ranked Majchrzak, who received the Challenger Tour occasion in Busan, South Korea in October and reached the semifinals of an ATP 250 occasion in Pune, India earlier this yr, didn’t present additional particulars concerning the banned substance.
The ITIA stated on Friday that Majchrzak had offered samples from tournaments at Sofia in September and Japan and Seoul in October which had been discovered to comprise three banned substances (SARM S-22, LGD-4033 and PPARδ agonists).
“I have some incredibly sad and difficult news to share with everyone. I have tested positive in anti-doping controls during October and November 2022,” Majchrzak wrote in a submit on Instagram on Thursday.
“Firstly, I have never, ever, knowingly taken any banned substance. At this moment I have no idea what has happened and this is the biggest shock.
“I have started the most difficult fight of my life – the fight to prove my innocence and to return to the sport I love.”
The ITIA stated the participant can request that his B samples are analysed to see in the event that they verify the A pattern findings.
“While provisionally suspended, he is ineligible to compete in or attend any sanctioned tennis events organised by the governing bodies of the sport,” the ITIA stated.